|
MDNAF Medicenna Therapeutics Corp 1807983 |
| Income Statement |
|
Net Income
|
2023-03-31
|
$-10,048,000.00 |
| Balance Sheet |
|
Current Assets
|
$36,385,000.00 |
|
Assets
|
$36,446,000.00 |
|
Current Liabilities
|
$3,800,000.00 |
|
Liabilities
|
$6,960,000.00 |
|
Equity
|
$29,486,000.00 |
|
Shares Out
|
69637469.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-12,657,000.00 |
| Market Analysis |
Market Cap
|
$17,409,367.25 |
|
Price
|
$0.25 |
|
BVPS
|
0.42 |
|
PB
|
0.60 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:58 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MDNAF documents filed with the SEC.
MDNAF Filings
Clear
